Evaluación del score cadillac como predictor de muerte a corto plazo en pacientes con síndrome coronario agudo sometidos a angioplastia, en Cardiocentro Angio Manabí. 2017-2018.

Abstract

Myocardial infarction is one of the leading causes of death in the world. Research reveals that in patients with acute myocardial infarction, early percutaneous coronary intervention delivers greater ventricular function recovery, of functional class, and early and late mortality, compared to another medical treatment. This research thesis was conducted at the “AngioManabí” Cadiac Center, during the 2018-2019 period, based on indirect observation of patients that went under angioplasty after an acute myocardial infarction, determining the short-term mortality of patients, using the CADILLAC Risk Score that weights 7 variables (baseline left ventricular ejection fraction <40, renal insufficiency, Killip class II – III, age >65 years, post-procedural TIMI flow grade 0 to 2, triple-vessel disease and anemia) in order to evaluate this score as a mortality predictor in patients. The universe was made up of all patients that met the inclusion and exclsuion criteria described in this research. Data was obtained from clinical health records. A 30 days mortality rate using the CADILLAC Risk Score was of 61.1%, which demostrates that is a good mortality predictor, being ejection fraction and anemia the most influencer variables.